Candriam S.C.A. Teva Pharmaceutical Industries LTD Transaction History

Candriam S.C.A.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 22, 2021	SELL	$8.61 - $11.04 $18,511 - $23,735	-2,150 Closed	0 $0
Q3 2020 Oct 19, 2020	BUY	$8.57 - $12.69 $18,425 - $27,283	2,150 New	2,150 $2.32 Million
Q2 2018 Aug 14, 2018	SELL	$16.77 - $24.71 $1.18 Million - $1.75 Million	-70,631 Closed	0 $0
Q1 2018 May 09, 2018	SELL	$16.68 - $22.07 $21,300 - $28,183	-1,277 Reduced 1.78%	70,631 $1.21 Million
Q4 2017 Feb 07, 2018	BUY	$11.23 - $19.1 $224,600 - $382,000	20,000 Added 38.53%	71,908 $1.36 Million
Q3 2017 Nov 03, 2017	BUY	$15.41 - $32.17 $799,902 - $1.67 Million	51,908	51,908 $914,000

625

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $25.3B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.